Literature DB >> 11977417

Biological versus ambient exposure monitoring of creosote facility workers.

Jonathan Borak1, Greg Sirianni, Howard Cohen, Susan Chemerynski, Frans Jongeneelen.   

Abstract

Traditional methods for monitoring occupational creosote exposure have focused on inhalation. However, there is evidence that dermal exposure contributes importantly to total systemic dose, as measured by biological monitoring methods. This study was conducted to further characterize the relationships between inhalation and dermal exposures to creosote, and to compare traditional ambient exposure monitoring versus biological monitoring in 36 creosote-exposed wood treatment workers. Full-shift personal air samples were obtained, along with post-shift and next-day urine measurements for 1-hydroxypyrene. There was little or no correlation between airborne measures and urinary 1-hydroxypyrene (r2 = 0.05 to 0.35). More than 90% of 1-hydroxypyrene could be attributed to dermal exposure. These data indicate that traditional monitoring methods may be inappropriate for creosote workers, raising concerns about the adequacy of methods currently mandated by the Occupational Safety and Health Administration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11977417     DOI: 10.1097/00043764-200204000-00011

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Simulation of urinary excretion of 1-hydroxypyrene in various scenarios of exposure to polycyclic aromatic hydrocarbons with a generic, cross-chemical predictive PBTK-model.

Authors:  Frans Jongeneelen; Wil ten Berge
Journal:  Int Arch Occup Environ Health       Date:  2011-10-29       Impact factor: 3.015

2.  Biological exposure indices of pyrrole adducts in serum and urine for hazard assessment of n-hexane exposure.

Authors:  Hongyin Yin; Chunling Zhang; Ying Guo; Xiaoying Shao; Tao Zeng; Xiulan Zhao; Keqin Xie
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.